Bank of America
BCLI

Bank of America’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bank of America’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-136
Closed -$152 – 8315
2025
Q2 		$152 Buy
136
+25
+23% +$28 ﹤0.01% 7892
2025
Q1 		$140 Buy
111
+5
+5% +$9 ﹤0.01% 7763
2024
Q4 		$241 Sell
106
-1
-0.9% -$2 ﹤0.01% 7555
2024
Q3 		$370 Buy
107
+8
+8% +$38 ﹤0.01% 7439
2024
Q2 		$504 Buy
99
+32
+48% +$240 ﹤0.01% 7360
2024
Q1 		$564 Sell
67
-3
-4% -$16 ﹤0.01% 7265
2023
Q4 		$287 Buy
70
+3
+4% +$9 ﹤0.01% 7328
2023
Q3 		$200 Sell
67
-278
-81% -$6.32K ﹤0.01% 7408
2023
Q2 		$10.7K Buy
345
+22
+7% +$912 ﹤0.01% 6844
2023
Q1 		$16K Sell
323
-66
-17% -$1.92K ﹤0.01% 6816
2022
Q4 		$9.56K Buy
389
+29
+8% +$1.08K ﹤0.01% 6928
2022
Q3 		$23K Sell
360
-147
-29% -$7.37K ﹤0.01% 6969
2022
Q2 		$21K Buy
507
+26
+5% +$1.17K ﹤0.01% 7168
2022
Q1 		$24K Buy
481
+275
+133% +$13.5K ﹤0.01% 7444
2021
Q4 		$12K Sell
206
-576
-74% -$28.4K ﹤0.01% 7652
2021
Q3 		$38K Sell
782
-1,639
-68% -$86.2K ﹤0.01% 7163
2021
Q2 		$138K Sell
2,421
-764
-24% -$40.8K ﹤0.01% 6319
2021
Q1 		$184K Buy
3,185
+60
+2% +$4.53K ﹤0.01% 6094
2020
Q4 		$213K Buy
3,125
+549
+21% +$74.8K ﹤0.01% 5556
2020
Q3 		$654K Sell
2,576
-1,692
-40% -$347K ﹤0.01% 4515
2020
Q2 		$718K Buy
4,268
+1,137
+36% +$123K ﹤0.01% 4364
2020
Q1 		$219K Buy
3,131
+1,598
+104% +$125K ﹤0.01% 5022
2019
Q4 		$98K Buy
1,533
+133
+10% +$7.71K ﹤0.01% 6005
2019
Q3 		$82K Hold
1,400
– – ﹤0.01% 6135
2019
Q2 		$83K Hold
1,400
– – ﹤0.01% 6087
2019
Q1 		$91K Buy
1,400
+67
+5% +$3.81K ﹤0.01% 5931
2018
Q4 		$71K Hold
1,333
– – ﹤0.01% 6074
2018
Q3 		$76K Hold
1,333
– – ﹤0.01% 6007
2018
Q2 		$78K Buy
1,333
+333
+33% +$19.6K ﹤0.01% 5913
2018
Q1 		$47K Hold
1,000
– – ﹤0.01% 6065
2017
Q4 		$59K Sell
1,000
-4
-0.4% -$239 ﹤0.01% 5993
2017
Q3 		$62K Buy
1,004
+4
+0.4% +$259 ﹤0.01% 5855
2017
Q2 		$62K Hold
1,000
– – ﹤0.01% 5787
2017
Q1 		$64K Hold
1,000
– – ﹤0.01% 5811
2016
Q4 		$38K Buy
1,000
+320
+47% +$11.1K ﹤0.01% 6049
2016
Q3 		$24K Buy
680
+10
+1% +$374 ﹤0.01% 6048
2016
Q2 		$24K Buy
+670
New +$23.5K ﹤0.01% 6159
2014
Q4 		– Sell
-2,889
Closed -$178K – 7675
2014
Q3 		$178K Buy
+2,889
New +$178K ﹤0.01% 5491

Other funds holding BCLI

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Bank of America's BCLI Position: Q3 2025 in Review

Bank of America sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q3 2025, closing a stake of 136 shares — an estimated $152 sold.

Bank of America first reported a position in BCLI in Q3 2014 and held it in 38 quarters. The position peaked at $718K in Q2 2020. 5 funds tracked by Wall St. Rank hold BCLI as of Q3 2025.

  • Bank of America reported no remaining BRAINSTORM CELL THERAPUTC position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 136 BRAINSTORM CELL THERAPUTC shares in Q3 2025, an estimated $152.
  • Bank of America first reported a position in BRAINSTORM CELL THERAPUTC in Q3 2014 and held it in 38 quarters.
  • Bank of America's BRAINSTORM CELL THERAPUTC position peaked at $718K in Q2 2020.
  • 5 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.